Accessibility Menu
Avvaa World Health Care Products logo

Avvaa World Health Care Products(OTC) AVVH

Market Cap$1.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2002)-100%
5 Year-95%
1 Year-55%
1 Month-16%
$0.00
-11.77%
-0.00Today
Avvaa World Health Care Products last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-04
Avvaa World Health Care Products stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-16.67%USD 0.002026-07-28
1 month-16.43%USD 0.002026-07-02
3 month-5.66%USD 0.002026-05-06
Year to date-66.67%USD 0.002025-12-31
1 year-54.55%USD 0.002025-08-04
3 year+7.14%USD 0.002023-08-04
5 year-95%USD 0.032021-08-05
Since inception-100%USD 76.002002-07-01

Avvaa World Health Care Products Financials at a Glance

Market Cap

$1.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$97.74K

Net Income (TTM)

-$32.81K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.03 (Low)

Price

$0.00

Volume

387,933

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

AVVH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Avvaa World Health Care Products

AVVAA World Health Care Products, Inc. is a global biotechnology firm focused on natural and therapeutic personal care solutions. The company specializes in developing, manufacturing, and distributing over-the-counter products, particularly the Neuroskin line, which addresses various skin irregularities.

Products and Services
  • Neuroskin product line for skin irregularities
  • Distribution rights for patented European skincare items
  • Natural grooming treatments for pets
Growth Outlook
  • Recent quarterly revenue increased to $25,901, showing potential for growth
  • Strong cash position with $192,742 in cash and cash equivalents
  • Long-term investments valued at $1,060,000 support future expansion
Financial Highlights
  • Trailing twelve months revenue of $109,221 indicates market demand
  • Current ratio of 8.16 suggests strong liquidity position
  • Net income for the latest quarter was -$22,969, reflecting ongoing challenges
AVVAA World Health Care Products, Inc. operates in a competitive market, focusing on innovative solutions for skin care and pet grooming. The company's Neuroskin line is designed to meet the needs of consumers seeking effective treatments for skin conditions. Recent financial data indicates a revenue increase, highlighting the potential for future growth. The strong liquidity position, as evidenced by a current ratio of 8.16, provides a solid foundation for operational stability. However, the company continues to face challenges, as reflected in the recent net income figures. Overall, AVVAA presents an intriguing opportunity for investors interested in the biotechnology and personal care sectors.
AI Generated • Jul 24, 2026

Industry

Biotechnology

Employees

2

CEO

Miguel Sanchez

Headquarters

Richmond, VA 23225, US

AVVH Financials

Key Financial Metrics (TTM)

Gross Margin

32.09%

Operating Margin

8.14%

Net Income Margin

-33.56%

Return on Equity

-67.34%

Return on Capital

-16.62%

Return on Assets

-2.33%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

966.44M

Volume

387.93K

Avg. Volume

192.07K

Financials (TTM)

Gross Profit

$31.36K

Operating Income

$7.95K

EBITDA

$7.95K

Operating Cash Flow

-$193.56K

Capital Expenditure

$0.54

Free Cash Flow

-$193.56K

Cash & ST Invst.

$192.74K

Total Debt

$1.25M

Avvaa World Health Care Products Performance Analysis

Avvaa World Health Care Products annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-05-31USD 0N/A
20232023-05-31USD 2,000N/A
20242024-05-31USD 0N/A
20252025-05-31USD 4,650N/A
Avvaa World Health Care Products sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-05-31N/A
Q12025-08-31496.0%
Q22025-11-3042.4%
Q32026-02-28-34.4%
Avvaa World Health Care Products annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-05-31USD 0.00N/A
20232023-05-31USD -0.00N/A
20242024-05-31USD 0.00N/A
20252025-05-31USD 0.00N/A
Avvaa World Health Care Products sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-05-31N/A
Q12025-08-31N/A
Q22025-11-30N/A
Q32026-02-28N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$25.90K

N/A

Gross Profit

$13.39K

N/A

Gross Margin

51.69%

N/A

Market Cap

$1.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$289.94K

N/A

Employees

5

N/A

Net Income

-$22.97K

-693.7%

EBITDA

-$11.78K

-1523.1%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$192.74K

+13917.6%

Total Debt

$1.25M

N/A

Accounts Receivable

$145.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.25M

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-2.33%

N/A

Return on Invested Capital

0.58%

N/A

Free Cash Flow

$1.05M

+5597.4%

Operating Cash Flow

$1.05M

+5597.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FUNRFunr
$0.00+0.00%
FORWForwardly Inc.
$0.00+0.00%
LZGILZG International, Inc.
$0.00+0.00%
MVCOMetavesco, Inc.
$0.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About AVVH

What is the current price of Avvaa World Health Care Products?

Avvaa World Health Care Products is trading at $0.00 per share.

What is the 52-week range for Avvaa World Health Care Products?

Over the past 52 weeks, Avvaa World Health Care Products has traded between $0.00 and $0.01.

How much debt does Avvaa World Health Care Products have?

As of the most recent reporting period, Avvaa World Health Care Products reported total debt of $1.25M.

How much cash does Avvaa World Health Care Products have on hand?

Avvaa World Health Care Products reported $192.74K in cash and cash equivalents in its most recent financial results.

What is Avvaa World Health Care Products’s dividend yield?

Avvaa World Health Care Products does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.